Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Correction: Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depression.
Farmer CA, Gilbert JR, Moaddel R, George J, Adeojo L, Lovett J, Nugent AC, Kadriu B, Yuan P, Gould TD, Park LT, Zarate CA Jr. Farmer CA, et al. Among authors: adeojo l. Neuropsychopharmacology. 2020 Jul;45(8):1405. doi: 10.1038/s41386-020-0699-7. Neuropsychopharmacology. 2020. PMID: 32376872 Free PMC article.
Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depression.
Farmer CA, Gilbert JR, Moaddel R, George J, Adeojo L, Lovett J, Nugent AC, Kadriu B, Yuan P, Gould TD, Park LT, Zarate CA Jr. Farmer CA, et al. Among authors: adeojo l. Neuropsychopharmacology. 2020 Jul;45(8):1398-1404. doi: 10.1038/s41386-020-0663-6. Epub 2020 Apr 6. Neuropsychopharmacology. 2020. PMID: 32252062 Free PMC article. Clinical Trial.
A Randomized Trial of the N-Methyl-d-Aspartate Receptor Glycine Site Antagonist Prodrug 4-Chlorokynurenine in Treatment-Resistant Depression.
Park LT, Kadriu B, Gould TD, Zanos P, Greenstein D, Evans JW, Yuan P, Farmer CA, Oppenheimer M, George JM, Adeojo LW, Snodgrass HR, Smith MA, Henter ID, Machado-Vieira R, Mannes AJ, Zarate CA. Park LT, et al. Int J Neuropsychopharmacol. 2020 Jul 29;23(7):417-425. doi: 10.1093/ijnp/pyaa025. Int J Neuropsychopharmacol. 2020. PMID: 32236521 Free PMC article. Clinical Trial.
Janus kinase (JAK) inhibition with baricitinib in refractory juvenile dermatomyositis.
Kim H, Dill S, O'Brien M, Vian L, Li X, Manukyan M, Jain M, Adeojo LW, George J, Perez M, Grom AA, Sutter M, Feldman BM, Yao L, Millwood M, Brundidge A, Pichard DC, Cowen EW, Shi Y, Lu S, Tsai WL, Gadina M, Rider LG, Colbert RA. Kim H, et al. Among authors: adeojo lw. Ann Rheum Dis. 2021 Mar;80(3):406-408. doi: 10.1136/annrheumdis-2020-218690. Epub 2020 Aug 25. Ann Rheum Dis. 2021. PMID: 32843325 Free PMC article. No abstract available.
Impact of a High-Fat Meal and Sprinkled Administration on the Bioavailability and Pharmacokinetics of Viloxazine Extended-Release Capsules (QelbreeTM) in Healthy Adult Subjects.
Wang Z, Kosheleff AR, Adeojo LW, Odebo O, Liranso T, Schwabe S, Nasser A. Wang Z, et al. Among authors: adeojo lw. Eur J Drug Metab Pharmacokinet. 2022 Jan;47(1):69-79. doi: 10.1007/s13318-021-00729-6. Epub 2021 Oct 15. Eur J Drug Metab Pharmacokinet. 2022. PMID: 34652564 Free PMC article. Clinical Trial.
Testing for Measurement Invariance (MI): Do the Structures of Microaggression, Discrimination, and Resilience Among Black Women Living with HIV Remain the Same Across Time?
Liu J, Feaster DJ, Shahid N, Lazarus K, Boga DJ, Willie P, Juste RS, Silva MF, Adeojo L, Wright M, Reid R, Gonzalez S, Madhu A, Warman C, Bolden R, Pan Y, Nelson CM, Hlaing W, Rodriguez A, Alcaide ML, Ironson G, Safren S, Wright I, Dale SK. Liu J, et al. Among authors: adeojo l. J Racial Ethn Health Disparities. 2024 Aug 5. doi: 10.1007/s40615-024-02087-w. Online ahead of print. J Racial Ethn Health Disparities. 2024. PMID: 39102174
13 results